If you suffer from depression, inflammation in your brain may contribute to your condition.
A handful of studies suggest that researchers are closing in on a causal relationship between “neuroinflammation” and depression.
The idea of inflammatory causes of depression has existed for a long time — perhaps decades, says behavioral health researcher Amit Anand, MD.
But interest in this area of research has grown in recent years. And it has improved in the era of biomarkers, measurable substances in your body that help indicate a disease or process.
In one of the most conclusive findings yet, a study in JAMA Psychiatry determined that brain inflammation was 30 percent higher in clinically depressed patients. The research team pointed out that previous studies have looked at biomarkers of inflammation in the blood. But this is the first to find definitive evidence in the brain.
Dr. Anand points to interesting research about the drug interferon, too. Doctors often use interferon to treat hepatitis C, but there’s often a troubling side effect: profound depression.
On the flipside, a 2013 JAMA Psychiatry article found that patients with mild inflammation who took infliximab — a medication used to treat autoimmune or inflammatory diseases — saw decreases in their depression symptoms.
There’s more work to do, Dr. Anand notes, but the evidence of a link between inflammation and depression is adding up.
Stress is also a factor
Stress is another part of the equation. Cleveland Clinic researchers have been looking at biomarkers for “blood-brain barrier” disruption or impairment. Sometimes, stress triggers certain proteins that have inflammatory properties to break through the barrier between the brain and the rest of the body.
A Cleveland Clinic study recently determined that children with emotional trauma had higher than normal levels of S100B, a biomarker of blood-brain barrier disruption and brain injury. Another study reported similar findings related to combat training stress in soldiers.
Proteins of this type have also been linked to depression.
In the long term, this link might offer hope for patients. Dr. Anand says future medications could potentially treat these types of impairments and help reverse depression.
Future research for patient solutions
Though the link is growing stronger, Dr. Anand cautions that doctors should not start handing out anti-inflammatory drugs just yet.
In most patients, inflammation might just be a contributing factor to depression, not the primary cause, he notes. He believes additional research could help solidify a causal relationship between inflammation, stress and depression — and determine whether medication can help.
The ideal, Dr. Anand says, would be to find a biomarker that definitively links inflammation to depression. Then, doctors could use that biomarker to identify at-risk patients.
“Those are the people you could treat with anti-inflammatory drugs,” he says.